Tag: APP

Blue Horseshoe Stocks: SITO, NFLX Options Recap & More

SITO Mobile Ltd.  SITO

SITO has most assuredly been one of this week’s top prospects. After noticing it coming up off its annual low toward the end of last week, we introduced this stock on Wednesday morning and briefly observed a low of.1489 followed by a day of strong upward momentum.

Yesterday’s report contained a reminder to that effect, noting that the stock had closed with strength on significantly heightened volume, leading us to believe that “opportunities may yet remain”. It turned out to be another great call as the stock attained a new high yesterday as it ran into the close and attained a PPS of .279

That means, in a span of just two days we witnessed an overall increase of 87% in SITO.

Netflix, Inc. NFLX – Options Ideas

The NFLX $395 and $410 Options Call ideas that we floated earlier this week continued to fare extremely well yesterday. NFLX surged to $429 in daily trading and as a result those contracts went absolutely haywire.

The $395 Calls ran from a low of 12.18 up as high as 34.35, for an impressive intraday jump equaling 182%

The $410’s put up an even better performance. Those contracts registered a daily range from 2.44 to 19.50; an incredible 699% run in a single session!

No matter how you look at it, the NFLX options chain has furnished us with some amazing chances this week, and we hope some of our readers were able to get in on the fun!

FXCM, Inc. FXCM

FXCM appeared on yesterday’s extended watchlist, and it too turned in a great performance on the day. The stock traded in a range from 2.49-3.51, marking a move of 41% on volume which exceeded the monthly average by more than 10X.

This was another one we caught coming up off of a recently established 52-week low, which provides another perfect example of why we’re constantly scouring the market for these types of bottom-plays.

Extended Watchlist:
VSTM, APP, FRO, VGGL

Blue Horseshoe Stocks: Revisiting TASR & More

TASER International, Inc. TASR

We’ve been tracking TASR since late November, and the stock has gained a good bit of ground over the last month, so we wanted to touch base and update readers on its performance so far. December 1st was the day we witnessed the low on TASR with the stock touching 20.79 during that session, and it hasn’t looked back yet.

Continuing orders from police agencies for TASER’s body-worn video cameras has fueled quite a run, as  the stock managed to break to new highs since we’ve been paying attention on Friday, despite the holiday-shortened week. TASR ran as high as 27.65, which, from the low we observed roughly one month ago, represents an increase of 33% It also puts the stock effectively in blue skies, trading as high as it has in ten years.

We like the trajectory TASR is on, with current events seeming to support a case for the stock going even higher. Amid growing calls for more law enforcement accountability from both the public and the agencies themselves, during a time when incidents between citizens and officials appear to be reaching critical levels, TASR is positioned perfectly to capitalize on the fallout. As we’ve mentioned before, TASER is a trusted name in law enforcement and the public arena, and thus a natural choice for technology that promises to create more transparency in local police departments. It makes it a story that we’re likely to follow over the long-term.


General Employment Enterprises, Inc. JOB

JOB has been on quite a run lately, coming up from the .20-range earlier this month, and we’re going to be monitoring the stock as we kick off another split-week. Over the past several sessions, JOB has pushed its way into blue sky breakout mode, and we’re going to be on the lookout for a continuation of the significant momentum that has been building in the stock.

At a certain point, profit-taking should begin to peel JOB back a bit, and so we’ll also be on the lookout for a dip-and-rip when that pullback leads to an eventual bounce.

American Apparel, Inc. APP

The last time we mentioned APP roughly a week back after seeing nearly 100% in gains, we gave the prices at which we wanted to see support hold as the .85-1.00 range. The stock has managed to maintain above a dollar for the most part, and we wanted to give it another nod this morning, and remind people that it still remains on our watchlist.

There seems to be a Golden Cross setting up on the chart, another reason why we want to establish a close watch over this play. Additionally, last year around this time and from roughly this price range, APP began a three-month run that brought it to well over two dollars. This has traditionally been a seasonal play for us, so we’re always open to the possibility of history repeating itself.

Extended Watchlist:
RXDX, LIVE, ADXS, BBEP

Blue Horseshoe Stocks: TRXC Recap & Much More

TransEnterix Inc. TRXC

TRXC stood out among the other mentions in Friday’s premarket report. Following our tag of this stock it shot quite rapidly from an early low of 2.73, and reached a subsequent high of 4.05 shortly after 11AM EST.

We want to congratulate any of our reader who were able to take advantage of that timely alert which yielded the opportunity at intraday gains of up to 48%  The healthy spike came on nearly tenfold the 3-month average trading volume.

Friday’s move came in conjunction with the announcement of successful pre-clinical trials for its SurgiBot minimally invasive surgery system. Two different doctors used TRXC’s product in actual medical procedures and subsequently offered their endorsements. It is an important step on the way to FDA application submission, which the company has stated should be on the table by mid-2015. Thus, TRXC may be one that we’ll want to have on a more long-term watch.

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced the successful completion of four general surgery and urology procedures using its SurgiBot system patient-side robotic surgery system. >> FULL PR

The First Marblehead Corp. FMD

We also wanted to give a quick nod to FMD for a solid performance following its inclusion in Friday morning’s watchlist. The stock found a low of 4.65 within the first several minutes of the open, and would go on to end the day with a on a high note, reaching as high as 5.35 and marking a respectable intraday move of 15%

Nuvilex, Inc. NVLX

Our first mention of NVLX dates all way back to August of 2013 when we released a special report on the company and its pancreatic cancer treatment, which at the time was in the early stages of Phase-2 trials. (Read the Special Report HERE)

A major development hit the presswires this morning regarding the FDA’s granting of ‘Orphan Drug’ status to that treatment, so we wanted to bring the stock back into the mix.

It’s coming off of a recent bottom as well, so NVLX is certainly going to be reserved a spot on our watchlist as the story continues to play out. The company has stated that Phase-3 trials should begin in 2015.

SILVER SPRING, Md., Dec. 22, 2014 (GLOBE NEWSWIRE) — Nuvilex, Inc. (NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Nuvilex orphan drug designation for its pancreatic cancer treatment. >> FULL PR

Rite-Aid Corp. RAD

We tagged RAD for tracking this past Tuesday, and the stock responded with a respectable performance on the week. An earnings beat as well as heightened guidance facilitated a healthy move from a low of 5.73 to a subsequent high of 7.05, marking a 23% intraweek spike.

Extended Watchlist:
GSS(Bottom Bouncer coming off 52-week lows), CANF, APP, TGE, ACHN